MENJAGA: Continuous Quality Improvement for Antenatal HIV, Syphilis and Hepatitis B Testing in Indonesia
NCT06058286 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000
Last updated 2023-09-28
Summary
Elimination of mother-to-child-transmission (EMTCT) of HIV, syphilis and hepatitis B are key priorities in Indonesia, the fourth most populous country in the world. Despite national guidelines and strong antenatal care attendance, coverage of antenatal screening for these diseases among pregnant women remains extremely limited in Indonesia. The Indonesian government is committed to improving the integration of HIV/syphilis/hepatitis B testing and treatment into the antenatal platform but currently lacks comprehensive evidence on interventions to support this. We will evaluate a low-cost and locally driven intervention based on the principles of continuous quality improvement to strengthen antenatal care and promote screening for HIV, syphilis and hepatitis B. Continuous Quality Improvement (CQI), which involves local antenatal care (ANC) teams systematically collecting and reflecting on local data to inform the design and implementation of service delivery, has been effectively used to strengthen ANC in a number of Sub-Saharan African countries but yet to be comprehensively evaluated in ANC services in Indonesia. This approach holds considerable promise for Indonesia, a highly populous and diverse country where a 'one size fits all' approach to the delivery of quality ANC rarely applies.
Conditions
- Hiv
- Syphilis
- Hepatitis B
Interventions
- OTHER
-
Continuous quality improvement
Continuous quality improvement (CQI) is an approach to develop healthcare providers' capacity to improve quality of care processes and improve adherence to clinical guidelines. Key features of CQI include systematic, data-guided activities, designing interventions (or changes to facility processes) with local conditions in mind, and iterative development and testing of interventions. The approach is based on the premise that valuable improvement in organisational processes can be achieved through bottom-up initiatives of stakeholders and providers. It requires a 'team-based' culture of staff working together to collect and use available data to evaluate the effect of local solutions. Facility staff drive the development of solutions to quality of care shortcomings that they feel are best suited to the local context, and CQI works within existing resource constraints so it does not require large long-term investments to sustain improvements.
Sponsors & Collaborators
-
London School of Hygiene and Tropical Medicine
collaborator OTHER -
Kirby Institute
collaborator OTHER_GOV -
Yanri Wijayanti Subronto, MD, PhD,
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-10-01
- Primary Completion
- 2024-10-31
- Completion
- 2024-12-31
Countries
- Indonesia
More Related Trials
-
Efficacy of HIV Post-Test Support for ANC in South Africa
NCT01683461 ·Status: COMPLETED ·Phase: NA
-
Swaziland Safe Generations
NCT01891799 ·Status: COMPLETED
-
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
NCT04405700 ·Status: RECRUITING
-
Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV
NCT06999928 ·Status: RECRUITING ·Phase: NA
-
Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine
NCT00000828 ·Status: COMPLETED
-
Introduction Study of Dual HIV & Syphilis Rapid Diagnostic Tests in Antenatal Clinics in Colombia
NCT02454816 ·Status: COMPLETED ·Phase: NA
-
A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
NCT00000910 ·Status: COMPLETED
-
Prospective Cohort Study of HIV and Zika in Infants and Pregnancy
NCT03263195 ·Status: COMPLETED
-
Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
NCT00639145 ·Status: COMPLETED
-
A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
NCT00341302 ·Status: COMPLETED
-
An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
NCT01836003 ·Status: COMPLETED ·Phase: NA
-
HIV Point-of-Care Test Evaluation in Infants
NCT02545296 ·Status: COMPLETED ·Phase: NA
-
Development of Resistance Mutations in Pregnant HIV-positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
NCT00197366 ·Status: TERMINATED
-
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 ·Status: COMPLETED ·Phase: NA
-
The Kabeho Study: Kigali Antiretroviral and Breastfeeding Assessment for the Elimination of HIV
NCT02295800 ·Status: COMPLETED
-
HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure
NCT03642704 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe
NCT04206241 ·Status: COMPLETED
-
Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
NCT01621347 ·Status: COMPLETED
-
STI Testing to Enhance PrEP Use in Pregnancy
NCT06919614 ·Status: RECRUITING ·Phase: PHASE3
-
Impact of Point-of-Care EID for HIV-Exposed Infants
NCT03824067 ·Status: COMPLETED ·Phase: NA
-
A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children
NCT00001106 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
NCT00000751 ·Status: COMPLETED ·Phase: PHASE3
-
Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids
NCT03284645 ·Status: COMPLETED
-
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
NCT00000960 ·Status: COMPLETED ·Phase: PHASE3
-
Healthy Beginning Initiative
NCT01795261 ·Status: UNKNOWN